Comparateur d'entreprises

À propos

Eli Lilly is the world's most valuable pharmaceutical company, propelled by the blockbuster GLP-1 receptor agonist tirzepatide (Mounjaro/Zepbound) for diabetes and obesity. Its Alzheimer's antibody donanemab and strong oncology pipeline give it one of the most promising drug portfolios in the industry.

Revenus

$52.8B

Signal d'écart de nouvelles

Signaux institutionnels

Modèles en cascade

Relations clés

À propos

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Revenus

$130.5B

Signal d'écart de nouvelles

Signaux institutionnels

Modèles en cascade

Relations clés